Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vitamin C and cancer revisited.

× No keyword cloud information.

19 in total

1. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

Authors: E Cameron; A Campbell
Journal: Chem Biol Interact Date: 1974-10 Impact factor: 5.192

Review 2. Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases.

Authors: E Cameron; L Pauling
Journal: Oncology Date: 1973 Impact factor: 2.935

Review 3. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress.

Authors: K J Davies
Journal: IUBMB Life Date: 1999-07 Impact factor: 3.885

4. Enhancement of antitumor activity of ascorbate against Ehrlich ascites tumor cells by the copper:glycylglycylhistidine complex.

Authors: E Kimoto; H Tanaka; J Gyotoku; F Morishige; L Pauling
Journal: Cancer Res Date: 1983-02 Impact factor: 12.701

5. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

Authors: E T Creagan; C G Moertel; J R O'Fallon; A J Schutt; M J O'Connell; J Rubin; S Frytak
Journal: N Engl J Med Date: 1979-09-27 Impact factor: 91.245

6. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.

Authors: L J Hoffer; M Levine; S Assouline; D Melnychuk; S J Padayatty; K Rosadiuk; C Rousseau; L Robitaille; W H Miller
Journal: Ann Oncol Date: 2008-06-09 Impact factor: 32.976

7. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

Authors: E Cameron; L Pauling
Journal: Proc Natl Acad Sci U S A Date: 1978-09 Impact factor: 11.205

8. Vitamin C pharmacokinetics: implications for oral and intravenous use.

Authors: Sebastian J Padayatty; He Sun; Yaohui Wang; Hugh D Riordan; Stephen M Hewitt; Arie Katz; Robert A Wesley; Mark Levine
Journal: Ann Intern Med Date: 2004-04-06 Impact factor: 25.391

9. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors: E Cameron; L Pauling
Journal: Proc Natl Acad Sci U S A Date: 1976-10 Impact factor: 11.205

10. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

Authors: C G Moertel; T R Fleming; E T Creagan; J Rubin; M J O'Connell; M M Ames
Journal: N Engl J Med Date: 1985-01-17 Impact factor: 91.245

37 in total

Review 1. Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors: Juan Du; Joseph J Cullen; Garry R Buettner
Journal: Biochim Biophys Acta Date: 2012-06-20

2. Fluorine-18-Labeled Thymidine Positron Emission Tomography (FLT-PET) as an Index of Cell Proliferation after Pharmacological Ascorbate-Based Therapy.

Authors: John A Cieslak; Zita A Sibenaller; Susan A Walsh; Laura L Boles Ponto; Juan Du; John J Sunderland; Joseph J Cullen
Journal: Radiat Res Date: 2015-12-31 Impact factor: 2.841

3. Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.

Authors: John A Cieslak; Robert K Strother; Malvika Rawal; Juan Du; Claire M Doskey; Samuel R Schroeder; Anna Button; Brett A Wagner; Garry R Buettner; Joseph J Cullen
Journal: Free Radic Biol Med Date: 2015-02-26 Impact factor: 7.376

4. Mega-dose vitamin C as therapy for human cancer?

Authors: Piet Borst
Journal: Proc Natl Acad Sci U S A Date: 2008-11-24 Impact factor: 11.205

5. Formation of a vitamin C conjugate of acrolein and its paraoxonase-mediated conversion into 5,6,7,8-tetrahydroxy-4-oxooctanal.

Authors: Nicholas G Kesinger; Brandi L Langsdorf; Alexandre F Yokochi; Cristobal L Miranda; Jan F Stevens
Journal: Chem Res Toxicol Date: 2010-04-19 Impact factor: 3.739

6. Transcriptional profiling of genes involved in ascorbic acid biosynthesis, recycling, and degradation during three leaf developmental stages in celery.

Authors: Wei Huang; Guang-Long Wang; Hui Li; Feng Wang; Zhi-Sheng Xu; Ai-Sheng Xiong
Journal: Mol Genet Genomics Date: 2016-09-07 Impact factor: 3.291

7. Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity.

Authors: Rupa R Sawant; Onkar Vaze; Gerard G M D'Souza; Karen Rockwell; Vladimir P Torchilin
Journal: Pharm Res Date: 2010-08-21 Impact factor: 4.200

8. Vitamin C improves the quality of somatic cell reprogramming.

Authors: Miguel A Esteban; Duanqing Pei
Journal: Nat Genet Date: 2012-03-28 Impact factor: 38.330

9. Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study.

Authors: Saroj Niraula; Greg Pond; Ronald de Wit; Mario Eisenberger; Ian F Tannock; Anthony M Joshua
Journal: Can Urol Assoc J Date: 2013 Jan-Feb Impact factor: 1.862

10. High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis.

Authors: Chang-Hwan Yeom; Gunsup Lee; Jin-Hee Park; Jaelim Yu; Seyeon Park; Sang-Yeop Yi; Hye Ree Lee; Young Seon Hong; Joosung Yang; Sukchan Lee
Journal: J Transl Med Date: 2009-08-11 Impact factor: 5.531